Open AccessTOX high mobility group box family member 3 rs3803662 and breast cancer risk
Author(s) -
Li Lin,
Guangcheng Guo,
Fang Wang,
Pengwei Lv,
Mingzhi Zhu,
Yuanting Gu,
Han Ming-li,
Xinhong Pei
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.167611
Subject(s) - breast cancer , odds ratio , confidence interval , estrogen receptor , medicine , meta analysis , subgroup analysis , genetic model , oncology , gynecology , cancer , biology , genetics , gene
Some studies suggested that TOX high mobility group box family member 3 (TOX3) rs3803662 polymorphism was associated with the risk of breast cancer. However, the results were controversy. Therefore, in order to derive a more comprehensive estimation of the association between TOX3 rs3803662 polymorphism and breast cancer risk, we conducted a meta-analysis to investigate this relationship.